1-5 of 5
Kutlu G Elpek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enabling Potent T Cell Delivery and Mitigating Key Off-Target Concerns of In Vivo CAR T Lentiviral Vectors with the Targeted Paramyxovirus Fusogen System

Shirisha Amatya, Jesse Green, Chi-Shuen Chu, Adam Hilterbrand, Reuben Burch, Chris Baldeviano, Edward Rebar, Terry J Fry, Albert Ruzo, Kutlu G Elpek, Kyle Trudeau
Journal: Blood
Blood (2024) 144 (Supplement 1): 2047.
https://doi.org/10.1182/blood-2024-211267
Published: 2024
Journal Articles

Relieving Restriction in Resting CD8+ T Cells Increases Gene Transfer and Improves Tumor Killing after Transduction with CD8-Targeted CD19CAR Fusosome

Mariliis Ott, Hadega Aamer, Daryl Humes, Reuben Burch, Christina Proano, Brian Dolinski, Diana Vedenova, Ashley Benson, Ryan White, Semih Tareen, Jesse Green, Kutlu G Elpek, Neal van Hoeven, Terry J Fry
Journal: Blood
Blood (2024) 144 (Supplement 1): 2196.
https://doi.org/10.1182/blood-2024-208368
Published: 2024
Journal Articles

Feasibility of Extracorporeal Delivery of Fusosomes to Generate CAR T Cells In Vivo

Jesse Green, Andrew Tucker, Aesha Vakil, Matt Scott-Skandera, Vasily Vagin, Dharmesh Dingar, Tarik Elgendi, Christina Proano, Brian Dolinski, Matthew A Lunning, Scott A Koepsell, Charles A Branson, Kerrie Enger, Danielle Quarles, Hosein Kouros-Mehr, Sarah Miller, Misha Shamashkin, Kutlu G Elpek
Journal: Blood
Blood (2023) 142 (Supplement 1): 3631.
https://doi.org/10.1182/blood-2023-186317
Published: 2023
Journal Articles

Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell Therapy

Vandana Chaturvedi, Jesse Green, Garrett Zipp, Aaron Lampano, Ouwen Liang, Allison O'Rourke, Brian Granger, Kutlu G Elpek, Neal van Hoeven, Terry Fry
Journal: Blood
Blood (2023) 142 (Supplement 1): 7121.
https://doi.org/10.1182/blood-2023-189669
Published: 2023
Journal Articles

GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition

Akinori Yoda, PhD, Guillaume Adelmant, PhD, Jerome Tamburini, MD PhD, Bjoern Chapuy, MD PhD, Nobuaki Shindoh, PhD, Yuka Yoda, MPh, Oliver Weigert, MD, Nadja Kopp, MA, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Amanda L Christie, Kutlu G Elpek, Joseph Card, Kira Gritsman, MD PhD, Jason Gotlib, MD MS, Michael W. Deininger, Hideki Makishima, MD PhD, Shannon Turley, PhD, Nathalie Javidi-Sharifi, Jaroslaw P. Maciejewski, MD PhD, Scott J Rodig, MD PhD, Jeffrey W. Tyner, Jarrod A Marto, PhD, David M. Weinstock, MD, Andrew A. Lane, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3567.
https://doi.org/10.1182/blood.V124.21.3567.3567
Published: 2014